Literature DB >> 28376944

Use of a Perianal Swab Compared With a Stool Sample to Detect Symptomatic Clostridium difficile Infection.

Marisa A Montecalvo1, Emnet Sisay1, Donna McKenna1, Guiqing Wang2, Paul Visintainer3, Gary P Wormser1.   

Abstract

OBJECTIVE To evaluate the use of a perianal swab to detect CDI. METHODS A perianal swab was collected from each inpatient with a positive stool sample for C. difficile (by polymerase chain reaction [PCR] test) and was tested for C. difficile by PCR and by culture. The variables evaluated included demographics, CDI severity, bathing before perianal swab collection, hours between stool sample and perianal swab, cycle threshold (Ct) to PCR positivity, and doses of CDI treatment before stool sample and before perianal swab. RESULTS Of 83 perianal swabs, 59 (71.1%) tested positive for C. difficile by PCR when perianal swabs were collected an average of 21 hours after the stool sample. Compared with the respective stool sample, the perianal sample was less likely to grow C. difficile (P=.005) and had a higher PCR Ct (P<.001). A direct, significant but weak correlation was detected between the Ct for a positive perianal sample and the respective stool sample (r=0.36; P=.006). An inverse dose relationship was detected between PCR positivity and CDI treatment doses before perianal swab collection (P=.27). CONCLUSION Perianal swabs are a simple method to detect C. difficile tcdB gene by PCR, with a sensitivity of 71%. These data were limited because stool samples and perianal swabs were not collected simultaneously. Compared with stool samples, the perianal Ct values and culture results were consistent with a lower bacterial load on the perianal sample due to the receipt of more CDI treatment before collection or unknown factors affecting perianal skin colonization. Infect Control Hosp Epidemiol 2017;38:658-662.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28376944     DOI: 10.1017/ice.2017.47

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  2 in total

1.  Identification of Clostridium innocuum hypothetical protein that is cross-reactive with C. difficile anti-toxin antibodies.

Authors:  K E Cherny; A Balaji; J Mukherjee; Y A Goo; A R Hauser; E Ozer; K J F Satchell; K E R Bachta; T J Kochan; S D Mitra; L K Kociolek
Journal:  Anaerobe       Date:  2022-03-31       Impact factor: 2.837

2.  Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.

Authors:  Ching-Chi Lee; Jen-Chieh Lee; Chun-Wei Chiu; Pei-Jane Tsai; Wen-Chien Ko; Yuan-Pin Hung
Journal:  Microbiol Spectr       Date:  2021-10-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.